Complications of Antiphospholipid Syndrome – APS Awareness Month Day 1 – APS Foundation of America
APS Foundation of America shared a post on LinkedIn:
“Complications of Antiphospholipid Syndrome – APS Awareness Month Day 1
Antiphospholipid syndrome (APS) can lead to several serious complications that significantly impact health.
One of the most notable complications is the increased risk of thrombosis, which can occur in both arteries and veins.
This leads to conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. Pregnant women with APS face heightened risks, including recurrent miscarriages, preterm birth, and placental issues, which can affect both mother and baby.
Moreover, APS can cause complications such as heart valve problems, known as Libman-Sacks endocarditis, which might lead to heart failure if untreated. Additionally, some individuals may develop neurological issues, including memory problems or dementia, due to reduced blood flow to the brain.
Managing APS is crucial, often involving blood thinners to prevent clot formation. Regular check-ups and working closely with healthcare providers can help mitigate these risks and improve quality of life.
If you have any questions or concerns about APS, don’t hesitate to reach out for more information or support.”
Stay updated with Hemostasis Today.
-
Jun 2, 2026, 14:00Wasimuddin Abdullah: Not Every Hilar ‘Mass’ Is a Mass
-
Jun 2, 2026, 13:53Brian Casey: SNMMI26 Image of the Year Highlights Novel DVT Imaging Technique
-
Jun 2, 2026, 13:47Zain Khalpey: The Path From Atherosclerosis to Heart Attack
-
Jun 2, 2026, 13:20Diana Pérez Moreno: Analgesic Efficacy and Safety of Erector Spinae Plane Block After Sternotomy and MICS
-
Jun 2, 2026, 13:15Gian Marco Petroni: Regional Anesthesia and Sedation for Hip Fracture Repair in Complex Patients
-
Jun 2, 2026, 13:04Open-Conformation ADAMTS13 R1206K as a Next-Generation Therapeutic Candidate for TTP – JTH
-
Jun 2, 2026, 11:04Melissa Glasner: The Safe and Effective Implementation of FXI/XIa Inhibitors Into Clinical Practice
-
Jun 2, 2026, 10:55Claudio Laudani: Not All ”Bi-Risk” PCI Patients Are Equal
-
Jun 2, 2026, 10:45Erin VanDyke: Creating a Multidisciplinary Forum Where VTE Remains a Visible Institutional Priority Is What Matters